Stock code: 002385 Stock abbreviation: DBN Announcement No.: 2023-040
Beijing DabeinongTechnology Group Co.,Ltd
19th Floor, Zhongguancun Building, 27 Zhongguancun Street,
Haidian District, Beijing
2022 Annual Report Summary
April 2023
I ImportantNotices
This summary is published in both Chinese and English. In case of any ambiguity, inconsistency or conflict between the two version,
the Chinese version shall prevail.
This Summary is based on the full annual report. Investors are kindly reminded to read the completed version of the aforesaid report
on the media designated by the China Securities Regulatory Commission (CSCR) to get complete information about the Company’s
business results, financial situation, and future development plans.
All directors have attended the Board meeting for the review of this annual report.
Notice of non-standard auditors’ opinions
□ Applicable Not applicable
A proposed profit distribution plan or a proposed plan on the conversion of capital reserves into share capital during the reporting
period was reviewed and approved by the Board
Applicable □ Not applicable
Conversion of capital reserves into share capital
□ Yes No
The proposed profit distribution plan approved by the Board is to be based on 4,137,906,853, distribute a cash dividend of RMB 0.5
(including tax) for every 10 shares to all shareholders, issue 0 bonus shares (including tax), and not convert capital reserves into share
capital.
The proposed profit distribution plan for preferredshares reviewed and approved by the Board during this reporting period
□ Applicable Not applicable
II BasicInformationofDBN
1. Company Profile
Stock abbreviation DBN Stock code 002385
Stock exchange for stock listing Shenzhen Stock Exchange
Abbreviation of the stock before Not applicable
alteration
Contact person and contact Board Secretary Securities affairs representative
information
Name Yin Wei Lei Zeli
Office address 1901A, 27 Zhongguancun Street, Haidian 1901A, 27 Zhongguancun Street, Haidian
District, Beijing District, Beijing
Fax 010-82472400 010-82472400
Telephone 010-82856450 15652078320
Email cwbgs@dbn.com.cn cwbgs@dbn.com.cn
2. Introduction to Main B us inesses orProducts during the Reporting Pe riod
The company's vision is to create a world-class agricultural technology and service company, based on agricultural high-te ch
enterprises, with industrial layout covering multiple fields such as feedtechnology, pig farming technology, crop technology, vaccine
and animal protection technology and etc. The feed technology industry is a leading domestic manufacturer of premix, educatio na l
trough feed, nursery feed, sow feed, and ruminant feed. The pig breeding technology industry relies on a good industrial foundation
and regional layout, promoting the "company+ecological farm" and "integrated" breeding model, and creating a unique joint pig
breeding development model. The crop technology industry adheres to the direction of technological innovation driven development,
with the goal of "creating world-class crop technology companies", focusing on the R&D and promotion of crop seed industries,
including biotechnology, corn seedindustry, rice seed industry, soybean seed industry, and economic seedindustry.
(1)Mainbus inesses
During the reporting period, DBN achieved an operating revenue of RMB 32,396.746 million yuan with a year-on-year increase of
3.41%, an operating profit of RMB 376.2072 million yuan with a YOY increase of 154.61%, a total profit of 317.5578 million yuan
with a YOY increase of 143.16%, and net profit attributable to shareholders of DBN 55.6018 million yuan with a YOY increase of
112.63%.
The company's main business income mainly comes from feed technology and pig farming technology. Throughout 2022, the
proportion of feed business revenue to main business revenue was 69.01%, that of pig farming business was 16.92%, that of seed
business was 2.91%, and that of veterinary drug and vaccine business was 0.89%.
Feedbusiness
With the continuous expansion of China’s feedindustry, DBN has gained a leading position in market competition with advantages in
scale, market coverage, technical services, and other aspects. At present, the standardized development of the industry in China
continuously improves the level of feed formula, with an accelerating penetration and promotion trend of antibiotic